Assoc. Prof. EBRU ESİN YÖRÜKER

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

609

H-Index (WoS)

Citation (Scopus)

661

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Total Citation Count

609

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

2003 - 2009

Doctorate

Istanbul University, Health Sciences Institute, Onkoloji Enstitüsü Bölümü, Turkey

1997 - 2000

Postgraduate

Istanbul University, Health Sciences Institute, Onkolojik Sitoloji Bd/Klinik Onkoloji Abd, Turkey

1993 - 1997

Undergraduate

Istanbul University, Faculty of Science, Biyoloji, Turkey

Dissertations

2009

Doctorate

Kolorektal kanserli hastalarda p16 tümör supressor genindeki promotor metilasyonu ve H3Lys9 metilasyonunun araştırılması

Istanbul University, Health Sciences Institute, Onkolojik Biyoloji Ve İmmunoloji Bd

2000

Postgraduate

Meme Karsinomlarının Sitolojik Materyalinde CD44 Gen Ekspresyonunun Nükeer Grad, Histolojik Grad ve Lenf Düğümü Metastazı ile İlişkisi

Istanbul University, Health Sciences Institute, Onkolojik Sitoloji Bd

Foreign Languages

B2 Upper Intermediate

English

Certificates, Courses and Trainings

2019

Eğiticinin Eğitimi Sertifikası

Education Management and Planning

İstanbul Üniversitesi Sürekli Eğitim Uygulama ve Araştırma Merkezi

2014

TS EN ISO 9001 Kalite Yönetim Sistemi Temel Eğitimi

Quality Management

Türk Standardları Enstütüsü Eğitim Daire Başkanlığı

2014

ISO 9001 Kalite Yönetim Sistemi-İç Tetkik Eğitimi

Quality Management

Türk Standartları Enstitüsü

2011

4th Course in Integration of Cytogenetics, Microarrays , European School of Genetic Medicine

Other

İstanbul Üniversitesi

1996

Öğretmenlik Formasyonu

Education Management and Planning

İstanbul Üniversitesi

Research Areas

Life Sciences

Molecular Biology and Genetics

Moleculer Biology of Cancer

Natural Sciences

Research Areas Based on Academic Activities

Avesis Research Areas

WoS Research Areas

Scopus Research Areas

Academic Positions

2017 - Present

Associate Professor

Istanbul University, Onkoloji Enstitüsü, Temel Onkoloji Ana Bilim Dalı

2003 - 2018

Research Assistant

Istanbul University, Onkoloji Enstitüsü, Temel Onkoloji Ana Bilim Dalı

Managerial Experience

2025 - Present

Sürdürülebilirlik Komisyonu

Istanbul University, Rektörlük

2024 - Present

Kalite Koordinatörü

Istanbul University, Rektörlük, Kalite Koordinatörlüğü

2024 - Present

Quality Coordinator

Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri

2023 - Present

Member of University Quality Commission

Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri

2022 - Present

Department Academic Incentive Evaluation Commission Member

Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri

2012 - Present

Member of Unit Quality Commission

Istanbul University, Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri

Non Academic Experience

2002 - 2002

Araştırmacı

Istituto Nazionale Per Lo Studio E La Cura Dei Tumori, Araştırmacı

Courses

Postgraduate

Onkolojik Biyoloji

Articles

2026

1. Quantification of the Human Satellite 2 (HSAT2) Repeat in the Plasma Cell-Free DNA of Patients with Colon Cancer

Yörüker E. E., Özgür E., Kulle C. B., Aksu B., Demir I. G., Bronkhorst A., et al.

Current Issues in Molecular Biology , vol.48, pp.1-11, 2026 (Peer-Reviewed Journal)

2025

2. Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma

Çiftçi M., Özgür E., Kulle C. B., Gezer U., Yörüker E. E.

Anticancer Research , vol.45, no.10, pp.4243-4251, 2025 (Peer-Reviewed Journal)

2025

3. A Narrative Review of the Role of Non-Viral Circulating Tumor DNA Profiling in Predicting the Treatment Response and Recurrence in Head and Neck Squamous Cell Carcinoma.

Gezer U., Meral R., Özgür E., Yörüker E. E., Bronkhorst A., Holdenrieder S.

Cancers , vol.17, no.14, 2025 (SCI-Expanded, Scopus)

2025

4. MODULATION OF PD-L1 EXPRESSION IN PROSTATE CANCER CELLS THROUGH ANDROGEN RECEPTOR INHIBITION DIFFERS DEPENDING ON RECEPTOR STATUS

Najafzadeh N., ÖZGÜR E., BİLGİÇ GAZİOĞLU S., YÖRÜKER E. E., GEZER U.

Experimental Oncology , vol.47, pp.60-67, 2025 (Peer-Reviewed Journal)

2024

5. LINE-1 cfDNA Methylation as an Emerging Biomarker in Solid Cancers.

Gezer U., Özgür E., Yörüker E. E., Polatoglou E., Holdenrieder S., Bronkhorst A.

Cancers , vol.16, no.22, 2024 (SCI-Expanded)

2024

6. The effect of radiation-induced genotoxic stress on the expression of satellite II and satellite III repeats in breast and colon cancer cells

YILMAZ E., ÖZGÜR E., Gazioglu S. B., Akbas C. K., GEZER U., YÖRÜKER E. E.

INTERNATIONAL JOURNAL OF RADIATION RESEARCH , no.1, 2024 (SCI-Expanded)

2023

7. Plasma Levels of Kynurenine, Soluble OX40 and Mir-138-5p Are Associated With Tumor-infiltrating Lymphocytes in Colorectal Cancer: An Exploratory Study

Zor D. S., Hakan M. T., Özgür E., Horozoglu C., Yörüker E. E., Kulle C. B., et al.

ANTICANCER RESEARCH , vol.43, no.7, pp.3281-3288, 2023 (SCI-Expanded)

2022

8. Androgen Receptor Blockade Using Enzalutamide Suppresses Long Non-Coding RNA ARLNC1 in Prostate Cancer Cells.

Huseynova G., Özgür E., Bilgiç Gazioğlu S., Esin Yörüker E. E., Gezer U.

Cell journal , vol.24, no.12, pp.774-778, 2022 (SCI-Expanded)

2022

9. Combining Histone ELISA and Quantitative PCR Assays to Extract and Quantify Histone Methylation-related Circulating DNA

ÖZGÜR E., YÖRÜKER E. E., KESKİN M., GEZER U.

Namık Kemal Tıp Dergisi , vol.10, no.1, pp.24-28, 2022 (Peer-Reviewed Journal)

2021

10. Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in Gastric Cancer

YÖRÜKER E. E., ÖZGÜR E., KESKİN M., ÖZGÜR İ., GEZER U.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.9, pp.720-726, 2021 (SCI-Expanded)

2021

11. Satellite 2 repeat DNA in blood plasma as a candidate biomarker for the detection of cancer

Özgür E., Mayer Z., Keskin M., Yörüker E. E., Holdenrieder S., Gezer U.

CLINICA CHIMICA ACTA , vol.514, pp.74-79, 2021 (SCI-Expanded)

2019

12. Plasma Histone H4 and H4K20 Trimethylation Levels Differ Between Colon Cancer and Precancerous Polyps.

Özgür E., Keskin M., Yörüker E. E., Holdenrieder S., Gezer U.

In vivo (Athens, Greece) , vol.33, pp.1653-1658, 2019 (SCI-Expanded)

2018

13. Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer

Yörüker E. E., Keskin M., Kulle C. B., Holdenrieder S., Gezer U.

BIOMEDICAL REPORTS , vol.9, no.2, pp.181-186, 2018 (ESCI)

2018

14. Potential of circulating nucleosome-associated histone modifications in cancer

Yörüker E. E., Holdenrieder S., Gezer U.

TRANSLATIONAL CANCER RESEARCH , vol.7, 2018 (SCI-Expanded)

2016

15. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer

Yörüker E. E., Holdenrieder S., Gezer U.

CLINICA CHIMICA ACTA , vol.455, pp.26-32, 2016 (SCI-Expanded)

2016

16. MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls

Yörüker E. E., Terzioglu D., Teksoz S., Uslu F. E., Gezer U., Dalay N.

JOURNAL OF CANCER , vol.7, no.7, pp.803-809, 2016 (SCI-Expanded)

2015

17. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer

Gezer U., Yörüker E. E., Keskin M., Kulle C. B., Dharuman Y., Holdenrieder S.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.16, no.12, pp.29654-29662, 2015 (SCI-Expanded)

2015

18. Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer

Yörüker E. E., Aydogan F., Gezer U., Saip P., Dalay N.

MOLECULAR AND CLINICAL ONCOLOGY , vol.3, no.4, pp.954-958, 2015 (ESCI)

2015

19. Assessment of circulating serum DNA integrity in colorectal cancer patients.

Yörüker E. E., Ozgur E., Keskin M., Dalay N., Holdenrieder S., Gezer U.

Anticancer research , vol.35, no.4, pp.2435-40, 2015 (SCI-Expanded)

2015

20. Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.

YÖRÜKER E. E., AYDOĞAN F., GEZER U., SAİP P. M., DALAY N.

Mol Clin Oncol. , vol.3, no.4, pp.954-958, 2015 (Peer-Reviewed Journal)

2014

21. HISTONE MODIFICATIONS IN CIRCULATING NUCLEOSOMES AS POTENTIAL NEW BIOMARKERS IN CANCER

Gezer U., Yoerueker E. E., Keskin M., Holdenrieder S., Dalay N.

ANTICANCER RESEARCH , vol.34, no.10, pp.5921-5922, 2014 (SCI-Expanded)

2014

22. Meme Karsinomunda CD44 Ekspresyonu

Yörüker E. E., MUTLU GÜNER S., Güler S. D., Alatlı F. C.

TÜRK ONKOLOJİ DERGİSİ , vol.29, no.1, pp.11-14, 2014 (Scopus)

2014

23. CD44S expression in breast carcinoma

YÖRÜKER E. E., Mutlu Guner S., Dolek Guler S., Alatli F. C.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.29, no.1, pp.11-14, 2014 (ESCI)

2013

24. Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer

Eralp Y., Keskin S., Akisik E. E., Akisik E., Igci A., Muslumanoglu M., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.36, no.3, pp.215-223, 2013 (SCI-Expanded, Scopus)

2013

25. Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer

Gezer U., Ustek D., Yoruker E. E., Cakiris A., Abaci N., LESZINSKI G., et al.

TUMOR BIOLOGY , vol.34, no.1, pp.329-336, 2013 (SCI-Expanded, Scopus)

2012

26. Promoter and histone methylation and p16(INK4A) gene expression in colon cancer

Yörüker E. E., Mert U., Bugra D., Yamaner S., Dalay N.

EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.4, no.5, pp.865-870, 2012 (SCI-Expanded)

2012

27. Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients.

Gezer U., Mert U., Ozgur E., Yörüker E. E., Holdenrieder S., Dalay N.

Oncology letters , vol.3, no.5, pp.1095-1098, 2012 (SCI-Expanded)

2008

28. Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma

Deligezer U., Akisik E. E., Erten N., Dalay N.

CLINICAL CHEMISTRY , vol.54, no.7, pp.1125-1131, 2008 (SCI-Expanded)

2008

29. Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy

Deligezer U., Eralp Y., Akisik E. E., Akisik E. Z., Saip P., Topuz E., et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.46, no.3, pp.311-317, 2008 (SCI-Expanded, Scopus)

2008

30. Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer

Deligezer U., Eralp Y., Akisik E. Z., Akisik E. E., Saip P., Topuz E., et al.

CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V , vol.1137, pp.175-179, 2008 (SCI-Expanded)

2007

31. Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia

Deligezer U., Akisik E. E., Dalay N.

ANTICANCER RESEARCH , vol.27, pp.2453-2456, 2007 (SCI-Expanded)

2007

32. A novel application of melting curves: utility of peak area calculation for relative methylation quantification

Deligezer U., Akisik E. E., Dalay N.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.45, no.7, pp.867-873, 2007 (SCI-Expanded)

2006

33. Methylation of the INK4A/ARF locus in blood mononuclear cells

Deligezer U., Erten N., Akisik E. E., Dalay N.

ANNALS OF HEMATOLOGY , vol.85, no.2, pp.102-107, 2006 (SCI-Expanded)

2006

34. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma

Deligezer U., Erten N., Akisik E. E., Dalay N.

EXPERIMENTAL AND MOLECULAR PATHOLOGY , vol.80, no.1, pp.72-76, 2006 (SCI-Expanded)

2006

35. MTHFR C677T gene polymorphism in lymphoproliferative diseases

Deligezer U., Akisik E. E., Yaman F., Erten N., Dalay N.

JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.20, no.2, pp.37-41, 2006 (SCI-Expanded)

2005

36. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population

Deligezer U., Akisik E. E., Dalay N.

IN VIVO , vol.19, no.5, pp.889-893, 2005 (SCI-Expanded)

2004

37. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients

Pagano G., Degan P., d'Ischia M., Kelly F., Pallardo F., Zatterale A., et al.

CARCINOGENESIS , vol.25, no.10, pp.1899-1909, 2004 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences

2025

1. Clinical significance of circulating H19 lncRNA and IGF-2 mRNA in colorectal carcinoma

Gezer U., Çiftci M., Özgür E., Kulle C. B., Yörüker E. E.

47TH CONFERENCE OF THE INTERNATIONAL SOCIETY OF ONCOLOGY AND BIOMARKERS , Munich, Germany, 13 - 16 October 2025, pp.98, (Summary Text)

2017

2. Circulating H4K20me3 and SUV420H2 mRNA in blood plasma of patients with colorectal cancer

YORUKER E. E., ÖZGÜR E., KESKİN M., GEZER U.

10th Internatioanl Syposium of Circulating Nucleic Acids in serum and Plasma, Montpellier, France, 20 - 22 September 2017, pp.32, (Full Text)

2017

3. Salivary Insulın like growth factor-1 and 8-hydroxy-2-deoxyguanosine levels in radioactive I131-treated patients with thyroid carcinoma

Batu Ş., Yörüker E. E.

11th European Symposium on Saliva, Amsterdam, Netherlands, 17 - 20 May 2017, pp.6, (Summary Text)

2016

4. Evaluation of Circulating Long Non-Coding RNA H9 and Cell-free Nucleosomes in Plasma of Patients with Gastric Cancer

YÖRÜKER E. E., KESKİN M., Koldemir O., KULLE C. B., GEZER U.

The 43rd International Society of Oncology and Biomarkers Annual Congress, Chicago, United States Of America, 1 - 06 September 2016, pp.6, (Full Text)

2015

5. Increased DNA Integrity of Free Serum DNA in Patients with Colorectal Cancer

YÖRÜKER E. E., ÖZGÜR E., KESKİN M., DALAY M. N., GEZER U.

The 42nd Congress of the International Society of Oncology and Biomarkers, Zakopane, Poland, 3 - 07 October 2015, pp.50-51, (Full Text)

2015

6. Histone methylation marks in circulating nucleosomes as novel biomarker in colorectal cancer

GEZER U., YÖRÜKER E. E., ÖZGÜR E., KESKİN M., Holdenrieder S.

IX. Circulating Nucleic Acids in Plasma and Serum, Berlin, Germany, 10 - 12 September 2015, pp.47, (Full Text)

2014

7. Serbest nükleozom ve DNA bütünlüğü kolorektal kanserleri için bir tarama ve takip yöntemi olarak kullanılabilir mi?

KESKİN M., YÖRÜKER E. E., Karip B., ÖZGÜR E., GEZER U., BULUT M. T., et al.

19. Ulusal Cerrahi Kongresi, Antalya, Turkey, 16 - 20 April 2014, pp.25, (Full Text)

2014

8. Circulating MicroRNA expression analysis in papillary thyroid carcinoma

YÖRÜKER E. E., Terzioğlu D., TEKSÖZ S., USLU F. E., GEZER U., DALAY M. N.

41 Congress of the International Society of Oncology and Biomarkers, Barselona, Spain, 15 - 18 March 2014, pp.27-28, (Full Text)

2013

9. **Kolorektal Kanser Hastalarında UGT1A1*28 Gen Polimorfizmi ve İrinotekan Toksisitesinin Araştırılması**

YÖRÜKER E. E., ŞEN F., Keskin S., AYKAN N. F., DALAY M. N.

XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Aydın, Turkey, 29 October - 01 November 2013, pp.196-197, (Full Text)

2013

10. Analysis of MRGBP and PPIL1 genes in colon cancer

YÖRÜKER E. E., DALAY M. N., Yamaner S., Buğra D.

Frontiers ib Basic Cancer Research, Maryland, United States Of America, 18 - 22 September 2013, pp.21, (Full Text)

2012

11. High-throughput sequencing of H3K9me3-and H4K20me3-associated circulating nucleosomal DNA

Gezer U., Ustek D., Yoruker E. E., Cakiris A., Abaci N., Leszinski G., et al.

40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, Israel, 13 - 17 October 2012, vol.33, pp.56, (Summary Text)

2011

12. Characterization of H3K9me3- and H4K20me3-associated nucleosomal DNA by high-throughput sequencing in colorectal cancer

GEZER U., ÜSTEK D., AKIŞIK E. E., ÇAKİRİS A., ABACI N., Holdenrieder S., et al.

7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19, (Full Text)

2011

13. The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Keskin S., Eralp Y., Yılmaz E. Z., YÖRÜKER E. E., İĞCİ A., MÜSLÜMANOĞLU M. E., et al.

2011 ASCO Annual Meeting, United States Of America, 1 - 04 June 2011, pp.10539, (Full Text)

2011

14. Kan dolaşımında histon modifikasyonlarının nükleozomlarla korelasyonu

GEZER U., Mert U., AKIŞIK E. E., DALAY M. N.

IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, (Full Text)

2009

15. H3K9me3/H4K2Ome3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer

Deligezer U., Akisik E. Z., Akisik E. E., Kovancilar M., Bugra D., Erten N., et al.

6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, PEOPLES R CHINA, 9 - 11 November 2009, pp.97-103, (Full Text)

2010

16. Histon modifications in circulating nucleosomes as potential biomarker in cancer

GEZER U., YÖRÜKER E. E., Yılmaz E. Z., Kovancılar M., Buğra D., Holdenrieder S., et al.

38th Meeting of the International Society of Oncology and Biomarkers (ISOBM), Germany, 1 - 04 September 2010, pp.34, (Full Text)

2009

17. H3K9me3/H4K20me3 ratio on circulating nucleosomes as potential biomarker for colorectal cancer

GEZER U., Akışık E. Z., AKIŞIK E. E., Kovancılar M., Buğra D., ERTEN S. N., et al.

6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, 1 - 04 November 2009, (Full Text)

2009

18. Kolorektal kanserli hastalarda p16 tümör süpressor genindeki promotör metilasyonu ve H3lys9 metilasyonunun araştırılması.

AKIŞIK E. E., Akışık E. Z., GEZER U., Buğra D., YAMANER Y. S., DALAY M. N.

XVIII. ULusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26, (Full Text)

2009

19. Kanserli hastaların periferik dolaşımlarında potansiyel biyomarker olarak histon modifikasyonları

GEZER U., Akışık E. Z., AKIŞIK E. E., Kovancılar M., Buğra D., ERTEN S. N., et al.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26, (Summary Text)

2008

20. Detection of Histone Methylation On Circulating Nuclesomes In Blood Plasma

GEZER U., YÖRÜKER E. E., Erten S., DALAY M. N.

ASCO Annual Meeting, United States Of America, 1 - 04 June 2008, pp.14590, (Full Text)

2008

21. Detection of histone methylation on circulating nucleosomes in blood plasma.

GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.

2008 ASCO Annual Meeting, United States Of America, 1 - 04 June 2008, (Full Text)

2008

22. Kan plazmasında serbest nükleozom ve DNA arasındaki kantitatif ilişkinin incelenmesi.

GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.

VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Turkey, 1 - 04 May 2008, pp.204, (Full Text)

2007

23. Size Distrubution Circulating Cell-Free DNA In Sera of Breast Cancer Patients In Course of Adjuvant Therapy

GEZER U., Eralp Y., YÖRÜKER E. E., Yılmaz E. Z., SAİP P. M., Topuz E., et al.

Symposium on Circulating Nucleic Acids in Plasma/Serum -V, Russia, 1 - 04 August 2007, pp.9, (Full Text)

2007

24. Size distribution o circulating cell-free DNA in sera of breast cancer aptients in course of adjuvant therapy

GEZER U., ERALP Y., AKIŞIK E. E., Akışık E. Z., SAİP P. M., Topuz E., et al.

Symposium on Circulating Nucleic Acids in Plasma Serum-V, Russia, 1 - 04 August 2007, pp.9, (Full Text)

2007

25. Plazma DNA bütünlüğünün kanserde biyomarker potansiyeli

GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.193-194, (Full Text)

26. Plazma Serbest DNA Bütünlüğünün Kanserde Biyomarker Potansiyeli

GEZER U., YÖRÜKER E. E., Erten N., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, pp.193-194, (Full Text)

2007

27. Myeloid lösemilerde XRCC1 geni kodon 399 polimorfizminin erime eğrisi analizi ile araştırılması

AKIŞIK E. E., GEZER U., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.194, (Full Text)

2005

28. Methylation of p16INK4A gene in plasma of patients with multiple myeloma

GEZER U., AKIŞIK E. E., DALAY M. N.

Symposium on Circulating Nucleic Acids in Plasm/Serum-IV, United Kingdom, 1 - 04 September 2005, pp.12, (Full Text)

2005

29. Lenfoma ve myelomalı hastaların periferik dolaşımlarında nükleozomal DNA fragmentasyonu ile kaspaz-3 ilişkisi

GEZER U., AKIŞIK E. E., AĞAOĞLU F., ERTEN S. N., DALAY M. N.

XVI. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2005, pp.197-188, (Summary Text)

2005

30. Hodgkin ve lenfoma ve B hücreli neoplazilerde MTHFR C677T gen polimorfizm dağılımının belirlenmesi

AKIŞIK E. E., GEZER U., AĞAOĞLU F., ERTEN S. N., DALAY M. N.

XVI. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2005, pp.194, (Full Text)

2003

31. Türk meme kanserli hastalarda XRCC1 gen polimorfizmi ve kanser riski ile ilişkisi

GEZER U., AKIŞIK E. E., DALAY M. N.

8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Turkey, 1 - 04 September 2003, pp.122, (Full Text)

2001

32. CD44 gene expression in breast carcinoma

YÖRÜKER E. E., ALATLI F. C., Özveren A., Dölek Güler S.

14 th International Congress of Cytology, Netherlands, 1 - 04 May 2001, pp.4, (Full Text)

2000

33. Cytopathological Features fo Follow-up Smears In Correlation With Clinical Features In Patients with Gynecological Cancer

ALATLI F. C., Küçücük S., YÖRÜKER E. E., Dölek Güler S., Özveren A., ASLAY I., et al.

The International Consensus Conference on the Fight Against Cervial Cancer, United States Of America, 1 - 04 March 2000, pp.1-2, (Full Text)

Books

2024

1. The Role of Mirnas in Control of K-ras Gene Expression

Kurt Gültaşlar B., Yörüker E. E.

in: Cancer: From Genomics to Pharmaceutics, KARAKAŞ ZEYNEP,ERDAL MERYEM SEDEF,SAYİTOĞLU MÜGE,SOLUK TEKKEŞİN MERVA, Editor, Istanbul University Press, İstanbul, pp.130-146, 2024

2020

2. Predictive and prognostic markers for cancer medicine

Yılmaz E. Z., Yörüker E. E.

in: Precision Medicine in Oncology, James Radosevic,Bulent Aydogan, Editor, Wiley-VCH Verlag Weinheim GmbH , Illinois, pp.157-201, 2020

2018

3. Ferroptosis

YÖRÜKER E. E., GEZER U.

in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018

2011

4. H3K9me3/H4K20me3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer

GEZER U., YÖRÜKER E. E., AKIŞIK E., KOVANCILAR M., BUĞRA D., Holdenrieder S., et al.

in: Circulating Nucleic Acids in Plasma and Serum, Graham PB, Editor, Springer, London/Berlin , Amsterdam, pp.97-103, 2011

Funded Projects

2025 - Present

Kolon kanserli hastaların kan plazmalarında miRNA profillerinin incelenmesi

Project Supported by Higher Education Institutions , BAP Research Project

ÖZGÜR E. (Executive), GEZER U., KULLE C. B., YÖRÜKER E. E.

2024 - Present

Sisplatin ile Muamele Edilen Kültür Hücrelerinde Histon Metilasyon (H3K9me2) Analizi

Project Supported by Higher Education Institutions , BAP MSc

YÖRÜKER E. E. (Executive), AKSU B.

2023 - 2025

Kolon Kanserinde Satellit 2 Tekrar Elementinin Sıvı Biyopsi Biyobelirteci Olarak İncelenmesi

TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects

(Project Abstract)

YÖRÜKER E. E. (Executive)

2023 - 2025

Kolorektal Kanserli Hastalar ile Sağlıklı Kişilerin Plazmalarında mir-483-5p, mir-195-5p ve mir-92a-3p İfade Düzeylerinin İncelenmesi

Project Supported by Higher Education Institutions , BAP Research Project

Yörüker E. E. (Executive), Özgür E., Kulle C. B., Yılmaz E. Z.

2022 - 2025

Kolorektal Kanserli Hastalar ile Sağlıklı Kişilerin Plazmalarında mir4835p, IGF2 ve h19 İfade Düzeylerinin İncelenmesi

Project Supported by Higher Education Institutions , BAP MSc

YÖRÜKER E. E. (Executive), ÇİFTÇİ M.

2021 - 2022

Prostat kanseri hücrelerinde androjen ile ölüm reseptör ligandı PD-L1 arasındaki ilişkinin incelenmesi

Project Supported by Higher Education Institutions , BAP MSc

YÖRÜKER E. E. (Executive), NAJAFZADE N.

2020 - 2022

Kolon Kanserinde Plazma Serbest DNA'sının Diagnostik Potansiyelinin Araştırılması

Project Supported by Higher Education Institutions , BAP Research Project

ÖZGÜR E. (Executive), GEZER U., YÖRÜKER E. E., KESKİN M.

2019 - 2022

Kanser Hücrelerinde Genotoksik Stres Varlığında Uydu DNA Transkriptlerinin İncelenmesi

Project Supported by Higher Education Institutions , BAP MSc

YÖRÜKER E. E. (Executive), YİLMAZ E.

2019 - 2021

Kasa invaze olmayan mesane kanserinde BCG tedavisinin etkinliğini değerlendirmede idrar ve periferik kanda biyobelirteç arayışı

Project Supported by Higher Education Institutions , BAP Other

YÖRÜKER E. E. (Executive), GEZER U.

2017 - 2018

Kolorektal kanserli hastaların kan plazmalarında SUV420H2 metiltransferaz ve H4K20me3 metillenme düzeyinde incelenmesi

Project Supported by Higher Education Institutions , BAP Research Project

GEZER U. (Executive), ÖZGÜR E., YÖRÜKER E. E., KESKİN M.

2017 - 2017

Salivary Insulin like growth factor1 and 8-hydroxy 2-deoxyguanosine levels in radioactive I131 treated patients with thyroid carcinoma

Project Supported by Higher Education Institutions , BAP Other

BATU Ş. (Executive), YÖRÜKER E. E.

2015 - 2017

Mide Kanserlerinde Tanı ve Tedavi Değerlendirilmesinde Serum Temelli H19, Serbest Nükleozom ve DNA Bütünlüğünün Biyomarker Olarak Değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Research Project

YÖRÜKER E. E. (Executive), KESKİN M., GEZER U.

2016 - 2016

Mide kanseri hastalarının plazmalarında H19 ekspresyonu ve serbest nükleozom miktarının değerlendirilmesi

Project Supported by Higher Education Institutions , BAP Other

YÖRÜKER E. E. (Executive), GEZER U., KESKİN M., KOLDEMİR O., KULLE C. B.

2016 - 2016

Serbest nükleozomların mide kanseri, inflamasyon ve kontrol grubunda karşılaştırılması

Project Supported by Higher Education Institutions , BAP Other

YÖRÜKER E. E. (Executive), GEZER U.

2015 - 2015

Kolorektal kanserli hastalarda serbest serum DNA'sının bütünlüğü

Project Supported by Higher Education Institutions , BAP Other

YÖRÜKER E. E. (Executive)

2014 - 2014

Sirküler miRNAların Papiller tiroid kanseri, benign tiroid nodülleri ve sağlıklı kontrollerde karşılaştırılması

Project Supported by Higher Education Institutions , BAP Other

YÖRÜKER E. E. (Executive)

2013 - 2014

Sirküler miRNA'ların papiller tiroid kanseri, benign tiroid nodülleri ve sağlıklı kontrollerde karşılaştırılması

Project Supported by Higher Education Institutions , BAP Research Project

YÖRÜKER E. E. (Executive)

2011 - 2013

Meme kanseri hastalarında serumda farklı miRNA'ların klinik özelliklerle karşılaştırılması

Project Supported by Higher Education Institutions , BAP Research Project

YÖRÜKER E. E. (Executive)

2009 - 2010

Kolorektal Kanserli Hastalarda p16 Tümör Süpressör Genindeki Promoter Metilasyonu ve H3lys-9 Metilayonunun Araştırılması

TUBITAK Project , 1002 - Quick Support Program

YÖRÜKER E. E., GEZER U. (Executive)

Peer Reviews in Scientific Publications

September 2023

BMC CANCER

Journal Indexed in SCI-E

September 2023

BMC CANCER

SCI Journal

July 2023

ONCOLOGY LETTERS

SCI Journal

June 2023

ONCOLOGY LETTERS

SCI Journal

January 2023

EXPERIMED

National Scientific Refreed Journal

May 2022

EXPERIMENTAL AND THERAPEUTIC MEDICINE

Journal Indexed in SCI-E

November 2021

Biomedical Reports

Journal Indexed in ESCI

June 2020

ONCOLOGY LETTERS

Journal Indexed in SCI-E

May 2020

ONCOLOGY LETTERS

Journal Indexed in SCI-E

March 2020

Molecular Medicine Reports

Journal Indexed in SCI-E

November 2019

Biochemical Genetics

SCI Journal

October 2019

International Journal Of Molecular Medicine

SCI Journal

September 2019

Oncology Letters

SCI Journal

August 2019

Oncology Letters /Spandidos

SCI Journal

August 2019

Molecular and Clinical Oncology/Spandidos

Other Indexed Journal

August 2018

Cellular Physiology and Biochemistry.

SCI Journal

January 2016

Mitochondrial Dna

SCI Journal

Scientific Project Refereeing

July 2024

Project Supported by Higher Education Institutions

BAP Research Project, Hacettepe University, Turkey

December 2023

Emergency R&D Project of Group A

Istanbul University, Turkey

November 2023

TUBITAK Project

1001 - Program for Supporting Scientific and Technological Research Projects, Istanbul University, Turkey

February 2023

Research Project of the Presidency of Turkey Health Institutes (TÜSEB)

Türkiye Sağlık Enstitüleri Başkanlığı, TÜSEB, Turkey

November 2022

Research Project of the Presidency of Turkey Health Institutes (TÜSEB)

Türkiye Sağlık Enstitüleri Başkanlığı, TÜSEB, Turkey

December 2021

Project Supported by Higher Education Institutions

BAP Research Project, Hacettepe University, Turkey

March 2021

Project Supported by Higher Education Institutions

BAP Research Project, Bursa Uludağ University, Turkey

January 2021

Project Supported by Higher Education Institutions

BAP Research Project, Bursa Uludağ University, Turkey

October 2020

TUBITAK Project

1011 - International Scientific Research Projects Participation Program (UBAP), Istanbul University, Turkey

October 2020

Project Supported by Higher Education Institutions

BAP Research Project, University Of Health Sciences, Turkey

January 2020

TUBITAK Project

1002 - Quick Support Program, Istanbul University, Turkey

Roles in Event Organizations

September 2016

43rd ISOBM Annual Congress

Scientific Congress

Yörüker E. E.

Illinois, United States Of America

Awards

April 2007

Size distrubution of circulating cell-free DNA in sera of breast cancer patients iin course of adjuvant therapy

Türk Kanser Araştırma ve Savaş Kurumu Birincilik Ödülü

Congress and Symposium Activities

01 December 2017 - 01 December 2017

IX. Aziz Sancar DETAE Günleri 'Deneysel Tıpta Yenilikler', İstanbul, Aralık 2017

Attendee

İstanbul-Turkey

01 September 2016 - 01 September 2016

43. International Society of Oncology and Biomarkers

Attendee

Illinois-United States Of America

01 September 2016 - 06 September 2016

43rd ISOBM Annual Congress

Session Moderator

Illinois-United States Of America

01 October 2015 - 01 October 2015

42. International Society of Oncology and Biomarkers

Attendee

Zakopane-Poland

01 April 2015 - 01 April 2015

21. Ulusal Kanser Kongresi

Attendee

Antalya-Turkey

01 March 2014 - 01 March 2014

41. International Society of Oncology and Biomarkers

Attendee

Barcelona-Spain

01 April 2013 - 01 April 2013

20. Ulusal Kanser Kongresi

Attendee

-Turkey

01 April 2011 - 01 April 2011

19. Ulusal Kanser Kongresi

Attendee

-Turkey

01 April 2009 - 01 April 2009

18. Ulusal Kanser Kongresi

Attendee

-Turkey

01 April 2007 - 01 April 2007

17. Ulusal Kanser Kongresi

Attendee

-Turkey

01 April 2005 - 01 April 2005

16. Ulusal Kanser Kongresi

Attendee

-Turkey

01 October 2003 - 01 October 2003

VIII. Ulusal Tıbbbi Biyoloji Kongresi

Attendee

Adana-Turkey

Citations

Total Citations (WOS): 610

h-index (WOS): 14

Jury Memberships

September-2023

September 2023

Doctorate

- İstanbul Üniversitesi-Cerrahpaşa

July-2023

July 2023

Post Graduate

- İstanbul Üniversitesi-Cerrahpaşa

June-2021

June 2021

PhD Thesis Monitoring Committee Member

- İstanbul Üniversitesi-Cerrahpaşa

September-2019

September 2019